Repligen Corporation (RGEN)
USD 147.34
(-6.83%)
USD 147.34
(-6.83%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 638.76 Million USD | -20.31% |
| 2022 | 801.53 Million USD | 19.54% |
| 2021 | 670.53 Million USD | 83.08% |
| 2020 | 366.26 Million USD | 35.53% |
| 2019 | 270.24 Million USD | 39.28% |
| 2018 | 194.03 Million USD | 37.38% |
| 2017 | 141.23 Million USD | 35.1% |
| 2016 | 104.54 Million USD | 25.14% |
| 2015 | 83.53 Million USD | 31.45% |
| 2014 | 63.54 Million USD | -6.78% |
| 2013 | 68.16 Million USD | 9.48% |
| 2012 | 62.26 Million USD | 128.16% |
| 2011 | 27.29 Million USD | 30.14% |
| 2010 | 20.97 Million USD | -28.58% |
| 2009 | 29.36 Million USD | 52.16% |
| 2008 | 19.29 Million USD | 37.1% |
| 2007 | 14.07 Million USD | 9.01% |
| 2006 | 12.91 Million USD | 37.94% |
| 2005 | 9.36 Million USD | 35.38% |
| 2004 | 6.91 Million USD | -11.03% |
| 2003 | 7.77 Million USD | 80.67% |
| 2002 | 4.3 Million USD | 83.3% |
| 2001 | 2.34 Million USD | -31.99% |
| 2000 | 3.45 Million USD | 32.72% |
| 1999 | 2.6 Million USD | 8.33% |
| 1998 | 2.4 Million USD | -36.84% |
| 1997 | 3.8 Million USD | -65.14% |
| 1996 | 10.9 Million USD | -35.5% |
| 1995 | 16.9 Million USD | -36.94% |
| 1994 | 26.8 Million USD | -1.83% |
| 1993 | 27.3 Million USD | 133.33% |
| 1992 | 11.7 Million USD | 53.95% |
| 1991 | 7.6 Million USD | -40.16% |
| 1990 | 12.7 Million USD | 49.41% |
| 1989 | 8.5 Million USD | -16.67% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 154.07 Million USD | 1.8% |
| 2024 Q1 | 151.34 Million USD | -2.82% |
| 2023 FY | 638.76 Million USD | -20.31% |
| 2023 Q2 | 159.16 Million USD | -12.86% |
| 2023 Q4 | 155.74 Million USD | 10.31% |
| 2023 Q3 | 141.19 Million USD | -11.29% |
| 2023 Q1 | 182.66 Million USD | -2.2% |
| 2022 Q4 | 186.76 Million USD | -6.96% |
| 2022 FY | 801.53 Million USD | 19.54% |
| 2022 Q2 | 207.63 Million USD | 0.6% |
| 2022 Q1 | 206.4 Million USD | 10.66% |
| 2022 Q3 | 200.74 Million USD | -3.32% |
| 2021 Q1 | 142.83 Million USD | 31.47% |
| 2021 Q4 | 186.52 Million USD | 4.66% |
| 2021 Q3 | 178.21 Million USD | 9.36% |
| 2021 Q2 | 162.96 Million USD | 14.09% |
| 2021 FY | 670.53 Million USD | 83.08% |
| 2020 Q1 | 76.09 Million USD | 9.52% |
| 2020 Q4 | 108.64 Million USD | 15.51% |
| 2020 Q3 | 94.06 Million USD | 7.54% |
| 2020 FY | 366.26 Million USD | 35.53% |
| 2020 Q2 | 87.46 Million USD | 14.95% |
| 2019 Q2 | 70.69 Million USD | 16.59% |
| 2019 FY | 270.24 Million USD | 39.28% |
| 2019 Q1 | 60.63 Million USD | 16.73% |
| 2019 Q4 | 69.47 Million USD | 0.04% |
| 2019 Q3 | 69.44 Million USD | -1.76% |
| 2018 Q4 | 51.94 Million USD | 4.87% |
| 2018 FY | 194.03 Million USD | 37.38% |
| 2018 Q1 | 44.83 Million USD | 7.74% |
| 2018 Q2 | 47.73 Million USD | 6.47% |
| 2018 Q3 | 49.52 Million USD | 3.77% |
| 2017 Q1 | 30.59 Million USD | 19.5% |
| 2017 Q2 | 32.45 Million USD | 6.1% |
| 2017 Q3 | 36.58 Million USD | 12.71% |
| 2017 Q4 | 41.61 Million USD | 13.75% |
| 2017 FY | 141.23 Million USD | 35.1% |
| 2016 FY | 104.54 Million USD | 25.14% |
| 2016 Q1 | 25.09 Million USD | 16.99% |
| 2016 Q2 | 29.17 Million USD | 16.24% |
| 2016 Q3 | 24.67 Million USD | -15.4% |
| 2016 Q4 | 25.59 Million USD | 3.74% |
| 2015 Q3 | 19.81 Million USD | -7.66% |
| 2015 Q2 | 21.45 Million USD | 3.08% |
| 2015 Q4 | 21.44 Million USD | 8.25% |
| 2015 Q1 | 20.81 Million USD | 26.98% |
| 2015 FY | 83.53 Million USD | 31.45% |
| 2014 Q3 | 15.27 Million USD | -1.75% |
| 2014 Q1 | 16.32 Million USD | 6.13% |
| 2014 Q2 | 15.55 Million USD | -4.75% |
| 2014 Q4 | 16.39 Million USD | 7.3% |
| 2014 FY | 63.54 Million USD | -6.78% |
| 2013 Q2 | 17.5 Million USD | 6.4% |
| 2013 Q4 | 15.38 Million USD | -18.27% |
| 2013 Q1 | 16.45 Million USD | -12.53% |
| 2013 FY | 68.16 Million USD | 9.48% |
| 2013 Q3 | 18.82 Million USD | 7.5% |
| 2012 Q3 | 15.1 Million USD | -2.7% |
| 2012 Q4 | 18.81 Million USD | 24.56% |
| 2012 Q1 | 12.82 Million USD | 0.0% |
| 2012 Q2 | 15.52 Million USD | 21.05% |
| 2012 FY | 62.26 Million USD | 128.16% |
| 2011 FY | 27.29 Million USD | 30.14% |
| 2011 Q4 | - USD | -100.0% |
| 2011 Q2 | 7.65 Million USD | 29.58% |
| 2011 Q1 | 5.9 Million USD | -16.43% |
| 2011 Q3 | 8.63 Million USD | 12.77% |
| 2010 Q3 | 7.3 Million USD | 4.24% |
| 2010 FY | 20.97 Million USD | -28.58% |
| 2010 Q4 | 7.06 Million USD | -3.27% |
| 2010 Q1 | 4.87 Million USD | -13.26% |
| 2010 Q2 | 7 Million USD | 43.87% |
| 2009 Q3 | 5.42 Million USD | 7.11% |
| 2009 Q1 | 4.59 Million USD | -23.66% |
| 2009 FY | 29.36 Million USD | 52.16% |
| 2009 Q2 | 5.06 Million USD | 10.17% |
| 2009 Q4 | 5.61 Million USD | 3.63% |
| 2008 Q2 | 13.66 Million USD | 313.85% |
| 2008 FY | 19.29 Million USD | 37.1% |
| 2008 Q1 | 3.3 Million USD | -29.23% |
| 2008 Q3 | 5.08 Million USD | -62.74% |
| 2008 Q4 | 6.01 Million USD | 18.23% |
| 2007 FY | 14.07 Million USD | 9.01% |
| 2007 Q3 | 5.35 Million USD | -10.48% |
| 2007 Q2 | 5.97 Million USD | 61.64% |
| 2007 Q4 | 4.66 Million USD | -12.85% |
| 2007 Q1 | 3.69 Million USD | -4.73% |
| 2006 Q4 | 3.88 Million USD | 35.52% |
| 2006 FY | 12.91 Million USD | 37.94% |
| 2006 Q1 | 2.88 Million USD | -3.43% |
| 2006 Q2 | 3.62 Million USD | 25.75% |
| 2006 Q3 | 2.86 Million USD | -21.04% |
| 2005 FY | 9.36 Million USD | 35.38% |
| 2005 Q4 | 2.98 Million USD | 6.72% |
| 2005 Q3 | 2.79 Million USD | -33.96% |
| 2005 Q2 | 4.23 Million USD | 41.57% |
| 2005 Q1 | 2.99 Million USD | 32.52% |
| 2004 Q2 | 2.8 Million USD | 32.92% |
| 2004 Q1 | 2.11 Million USD | 60.02% |
| 2004 Q3 | 1.29 Million USD | -53.85% |
| 2004 Q4 | 2.25 Million USD | 74.31% |
| 2004 FY | 6.91 Million USD | -11.03% |
| 2003 Q2 | 2.06 Million USD | 0.64% |
| 2003 FY | 7.77 Million USD | 80.67% |
| 2003 Q4 | 1.32 Million USD | -6.91% |
| 2003 Q3 | 1.41 Million USD | -31.15% |
| 2003 Q1 | 2.04 Million USD | -15.28% |
| 2002 Q4 | 2.41 Million USD | 43.23% |
| 2002 FY | 4.3 Million USD | 83.3% |
| 2002 Q1 | 1.52 Million USD | 29.03% |
| 2002 Q2 | 1.61 Million USD | 6.37% |
| 2002 Q3 | 1.68 Million USD | 4.2% |
| 2001 Q4 | 1.17 Million USD | 33.06% |
| 2001 Q3 | 886.73 Thousand USD | 24.45% |
| 2001 Q2 | 712.53 Thousand USD | -16.35% |
| 2001 Q1 | 851.75 Thousand USD | 38.46% |
| 2001 FY | 2.34 Million USD | -31.99% |
| 2000 Q3 | 465.41 Thousand USD | -29.57% |
| 2000 Q2 | 660.79 Thousand USD | -30.49% |
| 2000 FY | 3.45 Million USD | 32.72% |
| 2000 Q1 | 950.59 Thousand USD | 5.62% |
| 2000 Q4 | 615.15 Thousand USD | 32.17% |
| 1999 Q2 | 700 Thousand USD | -22.22% |
| 1999 FY | 2.6 Million USD | 8.33% |
| 1999 Q1 | 900 Thousand USD | 80.0% |
| 1999 Q4 | 900 Thousand USD | -10.0% |
| 1999 Q3 | 1 Million USD | 42.86% |
| 1998 Q2 | 600 Thousand USD | 20.0% |
| 1998 Q1 | 500 Thousand USD | -37.5% |
| 1998 Q3 | 800 Thousand USD | 33.33% |
| 1998 FY | 2.4 Million USD | -36.84% |
| 1998 Q4 | 500 Thousand USD | -37.5% |
| 1997 Q4 | 800 Thousand USD | 60.0% |
| 1997 Q3 | 500 Thousand USD | -28.57% |
| 1997 Q2 | 700 Thousand USD | -22.22% |
| 1997 Q1 | 900 Thousand USD | -18.18% |
| 1997 FY | 3.8 Million USD | -65.14% |
| 1996 FY | 10.9 Million USD | -35.5% |
| 1996 Q4 | 1.1 Million USD | 10.0% |
| 1996 Q3 | 1 Million USD | 25.0% |
| 1996 Q2 | 800 Thousand USD | -11.11% |
| 1996 Q1 | 900 Thousand USD | -57.14% |
| 1995 Q1 | 5.1 Million USD | 41.67% |
| 1995 FY | 16.9 Million USD | -36.94% |
| 1995 Q4 | 2.1 Million USD | -58.0% |
| 1995 Q3 | 5 Million USD | 78.57% |
| 1995 Q2 | 2.8 Million USD | -45.1% |
| 1994 FY | 26.8 Million USD | -1.83% |
| 1994 Q4 | 3.6 Million USD | 5.88% |
| 1994 Q2 | 4.8 Million USD | -26.15% |
| 1994 Q1 | 6.5 Million USD | -2.99% |
| 1994 Q3 | 3.4 Million USD | -29.17% |
| 1993 Q3 | 6.8 Million USD | 9.68% |
| 1993 Q4 | 6.7 Million USD | -1.47% |
| 1993 Q2 | 6.2 Million USD | -36.73% |
| 1993 Q1 | 9.8 Million USD | 127.91% |
| 1993 FY | 27.3 Million USD | 133.33% |
| 1992 Q3 | 5.2 Million USD | -41.57% |
| 1992 Q4 | 4.3 Million USD | -17.31% |
| 1992 FY | 11.7 Million USD | 53.95% |
| 1992 Q1 | 4.7 Million USD | 104.35% |
| 1992 Q2 | 8.9 Million USD | 89.36% |
| 1991 Q2 | 2.7 Million USD | 2800.0% |
| 1991 Q1 | -100 Thousand USD | -104.0% |
| 1991 FY | 7.6 Million USD | -40.16% |
| 1991 Q3 | 2 Million USD | -25.93% |
| 1991 Q4 | 2.3 Million USD | 15.0% |
| 1990 Q2 | 2.6 Million USD | -39.53% |
| 1990 Q4 | 2.5 Million USD | 0.0% |
| 1990 FY | 12.7 Million USD | 49.41% |
| 1990 Q3 | 2.5 Million USD | -3.85% |
| 1990 Q1 | 4.3 Million USD | 19.44% |
| 1989 FY | 8.5 Million USD | -16.67% |
| 1989 Q4 | 3.6 Million USD | 33.33% |
| 1989 Q3 | 2.7 Million USD | 8.0% |
| 1989 Q2 | 2.5 Million USD | 13.64% |
| 1989 Q1 | 2.2 Million USD | -18.52% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 96.63 Million USD | -561.021% |
| AngioDynamics, Inc. | 303.91 Million USD | -110.179% |
| AtriCure, Inc. | 399.24 Million USD | -59.993% |
| Avinger, Inc. | 7.65 Million USD | -8247.674% |
| Azenta, Inc. | 665.07 Million USD | 3.956% |
| BioLife Solutions, Inc. | 143.27 Million USD | -345.843% |
| The Cooper Companies, Inc. | 3.59 Billion USD | 82.223% |
| Daxor Corporation | 1.28 Million USD | -49783.367% |
| Ekso Bionics Holdings, Inc. | 18.27 Million USD | -3394.524% |
| Femasys Inc. | 1.07 Million USD | -59487.862% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 112.25 Million USD | -469.055% |
| Hologic, Inc. | 4.03 Billion USD | 84.151% |
| ICU Medical, Inc. | 2.25 Billion USD | 71.725% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | 91.034% |
| KORU Medical Systems, Inc. | 28.51 Million USD | -2139.889% |
| LeMaitre Vascular, Inc. | 193.48 Million USD | -230.138% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -55325.218% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -55325.218% |
| Masimo Corporation | 2.04 Billion USD | 68.812% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 97.09 Million USD | -557.849% |
| Merit Medical Systems, Inc. | 1.25 Billion USD | 49.198% |
| Nephros, Inc. | 14.23 Million USD | -4386.332% |
| NovoCure Limited | 509.33 Million USD | -25.411% |
| NEXGEL, Inc. | 4.08 Million USD | -15521.521% |
| NEXGEL, Inc. | 4.08 Million USD | -15521.521% |
| Singular Genomics Systems, Inc. | 2.91 Million USD | -21843.112% |
| OraSure Technologies, Inc. | 405.47 Million USD | -57.536% |
| Pro-Dex, Inc. | 53.84 Million USD | -1086.323% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 1.78 Million USD | -35783.743% |
| Precision Optics Corporation, Inc. | 19.1 Million USD | -3243.553% |
| QuidelOrtho Corporation | 2.99 Billion USD | 78.692% |
| Sanara MedTech Inc. | 64.98 Million USD | -882.867% |
| STAAR Surgical Company | 322.41 Million USD | -98.119% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 50.22 Million USD | -1171.83% |
| DENTSPLY SIRONA Inc. | 3.96 Billion USD | 83.89% |
| Jin Medical International Ltd. | 19.82 Million USD | -3122.589% |